{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:12:23Z","timestamp":1762099943500},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/bcr293","type":"journal-article","created":{"date-parts":[[2002,9,26]],"date-time":"2002-09-26T12:07:27Z","timestamp":1033042047000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Expression of LRP and MDR1 in locally advanced breast cancer predicts axillary node invasion at the time of rescue mastectomy after induction chemotherapy"],"prefix":"10.1186","volume":"3","author":[{"given":"Jos\u00e9","family":"Schneider","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Severino","family":"Gonzalez-Roces","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Poll\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raul","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando","family":"Tejerina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Alba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2001,6,1]]},"reference":[{"key":"298_CR1","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/BF02303476","volume":"5","author":"HM Kuerer","year":"1998","unstructured":"Kuerer HM, Newman LA, Fornage BD, Dhingra K, Hunt KK, Buzdar AU, Ames FC, Ross MI, Feig BW, Hortobagyi GN, Singletary SE: Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer. Ann Surg Oncol. 1998, 5: 673-680.","journal-title":"Ann Surg Oncol"},{"key":"298_CR2","first-page":"153","volume-title":"In Breast Cancer. Atlas of Clinical Oncology. Edited by Winchester DJ, Winchester DP. London: B.C. Decker Inc,","author":"SE Singletary","year":"2000","unstructured":"Singletary SE: Locally advanced breast cancer. In Breast Cancer. Atlas of Clinical Oncology. Edited by Winchester DJ, Winchester DP. London: B.C. Decker Inc,. 2000, 153-170."},{"key":"298_CR3","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1007\/s10434-999-0762-4","volume":"6","author":"JT Lenert","year":"1999","unstructured":"Lenert JT, Vlastos G, Mirza NQ, Winchester DJ, Binkley SM, Ames FC, Ross MI, Feig BW, Hunt KK, Strom E, Buzdar AU, Hortobagyi GN, Singletary SE: Primary tumor response to induction chemotherapy as a predictor of histological status of axillary nodes in operable breast cancer. Ann Surg Oncol. 1999, 6: 762-767.","journal-title":"Ann Surg Oncol"},{"key":"298_CR4","first-page":"202","volume":"181","author":"C Botti","year":"1995","unstructured":"Botti C, Vici P, Lopez M, Scinto AF, Cognetti F, Cavaliere R: Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast. J Am Coll Surg. 1995, 181: 202-208.","journal-title":"J Am Coll Surg"},{"key":"298_CR5","first-page":"230","volume":"4","author":"HM Kuerer","year":"1998","unstructured":"Kuerer HM, Newman LA, Buzdar AU, Dhingra K, Hunt KK, Buchholz TA, Binkley SM, Strom EA, Ames FC, Ross MI, Feig BW, McNeese MD, Hortobagyi GN, Singletary SE: Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status. Cancer J Sci Am. 1998, 4: 230-236.","journal-title":"Cancer J Sci Am"},{"key":"298_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1023\/A:1005739525196","volume":"42","author":"HC Chung","year":"1997","unstructured":"Chung HC, Rha SY, Kim JH, Roh JK, Min JS, Lee KS, Kim BS, Lee KB: P-glycoprotein: the intermediate end point of drug response to induction chemotherapy in locally advanced breast cancer. Breast Cancer Res Treat. 1997, 42: 65-72. 10.1023\/A:1005739525196.","journal-title":"Breast Cancer Res Treat"},{"key":"298_CR7","first-page":"2905","volume":"18","author":"M Volm","year":"1998","unstructured":"Volm M: Multidrug resistance and its reversal. Anticancer Res. 1998, 18: 2905-2917.","journal-title":"Anticancer Res"},{"key":"298_CR8","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1093\/jnci\/87.16.1230","volume":"87","author":"MA Izquierdo","year":"1995","unstructured":"Izquierdo MA, van der Zee AG, Vermorken JB, van der Valk P, Belien JA, Giaccone G, Scheffer GL, Flens MJ, Pinedo HM, Kenemans P, Meijer CJLM, de Vries EGE, Scheper RJ: Drug-resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma. J Natl Cancer Inst. 1995, 87: 1230-1237.","journal-title":"J Natl Cancer Inst"},{"key":"298_CR9","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/00001813-199708000-00003","volume":"8","author":"M Volm","year":"1997","unstructured":"Volm M, Stammler G, Zintl F, Koomagi R, Sauerbrey A: Expression of lung-resistance protein (LRP) in initial and relapsed childhood acute lymphoblastic leukemia. Anticancer Drugs. 1997, 8: 662-665.","journal-title":"Anticancer Drugs"},{"key":"298_CR10","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/00001622-200011000-00007","volume":"12","author":"GL Scheffer","year":"2000","unstructured":"Scheffer GL, Schroeijers AB, Izquierdo MA, Wiemer EA, Scheper RJ: Lung resistance-related protein\/major vault protein and vaults in multidrug-resistant cancer. Curr Opin Oncol. 2000, 12: 550-556. 10.1097\/00001622-200011000-00007.","journal-title":"Curr Opin Oncol"},{"key":"298_CR11","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1097\/00001813-199711000-00003","volume":"8","author":"M Volm","year":"1997","unstructured":"Volm M, Mattern J, Koomagi R: Expression of lung resistance-related protein (LRP) in non-small cell lung carcinomas of smokers and non-smokers and its predictive value for doxorubicin resistance. Anticancer Drugs. 1997, 8: 931-936.","journal-title":"Anticancer Drugs"},{"key":"298_CR12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein R, Verweij J, van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG: New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst. 2000, 92: 205-216. 10.1093\/jnci\/92.3.205.","journal-title":"J Natl Cancer Inst"},{"key":"298_CR13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1159\/000030096","volume":"20","author":"J Schneider","year":"1999","unstructured":"Schneider J, Poll\u00e1n M, Ruibal A, Jim\u00e9nez E, Lucas AR, N\u00fa\u00f1ez MI, S\u00e1nchez J, Tejerina A: Histologic grade and CD44 are independent predictors of axillary node invasion in early (T1) breast cancer. Tumor Biol. 1999, 20: 319-330. 10.1159\/000030096.","journal-title":"Tumor Biol"},{"key":"298_CR14","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/bjc.1989.372","volume":"60","author":"J Schneider","year":"1989","unstructured":"Schneider J, Bak M, Efferth T, Kaufmann M, Mattern J, Volm M: P glycoprotein expression in treated and untreated human breast cancer. Br J Cancer. 1989, 60: 815-818.","journal-title":"Br J Cancer"},{"key":"298_CR15","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1093\/jnci\/86.11.850","volume":"86","author":"J Schneider","year":"1994","unstructured":"Schneider J, Rubio MP, Barbazan MJ, Rodriguez-Escudero FJ, Seizinger BS, Castresana JS: P-glycoprotein, HER-2\/neu and mutant p53 expression in human gynecologic tumors. J Natl Cancer Inst. 1994, 86: 850-855.","journal-title":"J Natl Cancer Inst"},{"key":"298_CR16","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1093\/jnci\/89.13.917","volume":"89","author":"BJ Trock","year":"1997","unstructured":"Trock BJ, Leonessa F, Clarke R: Multidrug-resistance in breast cancer: a meta-analysis of MDR1\/gp170 expression and its possible functional significance. J Natl Cancer Inst. 1997, 89: 917-931. 10.1093\/jnci\/89.13.917.","journal-title":"J Natl Cancer Inst"},{"key":"298_CR17","first-page":"1117","volume":"15","author":"J Schneider","year":"1995","unstructured":"Schneider J, Romero H: Correlation of P-glycoprotein overexpression and cellular prognostic factors in formalin-fixed, paraffin-embedded tumor samples from breast cancer patients. Anticancer Res. 1995, 15: 1117-1121.","journal-title":"Anticancer Res"},{"key":"298_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/jnci\/83.2.111","volume":"83","author":"P Verrelle","year":"1991","unstructured":"Verrelle P, Meisonnier F, Fonck Y, Feillel V, Dionet C, Kwiatkowski F, Plagne R, Chassagne J: Clinical relevance of immunohistochemical detection of multidrug resistance P-glycoprotein in breast carcinoma. J Natl Cancer Inst. 1991, 83: 111-116.","journal-title":"J Natl Cancer Inst"},{"key":"298_CR19","first-page":"2147","volume":"17","author":"J Schneider","year":"1997","unstructured":"Schneider J, Centeno M, Jimenez E, Rodriguez-Escudero FJ, Romero H: Correlation of MDR1 expression and oncogenic activation in human epithelial ovarian carcinoma. Anticancer Res. 1997, 17: 2147-2152.","journal-title":"Anticancer Res"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr293.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/bcr293\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr293.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T16:24:04Z","timestamp":1714062244000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6,1]]},"references-count":19,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2001,6]]}},"alternative-id":["298"],"URL":"https:\/\/doi.org\/10.1186\/bcr293","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6,1]]},"assertion":[{"value":"30 August 2000","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2001","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2001","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2001","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"183"}}